• Vaxzevria (ChAdOx1-S) COVID-19 vaccine (‘AstraZeneca vaccine’)
• Comirnaty (BNT162b2 ) COVID-19 vaccine (‘Pfizer vaccine’)
• Spikevax (elasomeran) COVID-19 vaccine (‘Moderna vaccine’)
• Nuvaxovid COVID-19 vaccine (‘Novavax vaccine’)

• AstraZeneca (Vaxzevria): 18 years (reason: NSW Pharmacist Vaccination Standards)
• Pfizer (Comirnaty) (purple/grey cap): 12 years (reason: NSW Pharmacist Vaccination Standards)
• Moderna (Spikevax): 6 years (reason: NSW Pharmacist Vaccination Standards)
• Pfizer 5-11 years (orange cap): 5 years (reason: NSW Pharmacist Vaccination Standards)
• Novavax (Nuvaxovid): 18 years (reason: NSW Pharmacist Vaccination Standards)

• Community pharmacies approved under Schedule 5F of the Health Practitioner Regulation National Law (NSW)*
• Residential care facility
• General Practice clinic*
• Aboriginal Medical Services*
• A person’s home
• Public, private or independent schools
• NSW Health facilities**
• Staff Occupational Health Clinic (clinics held in the workplace to vaccinate staff)

* Must be registered to participate in the COVID-19 vaccination program

** NSW Health directives apply to regulations for pharmacists vaccinating within NSW Health facilities, such as vaccination hubs and hospitals.

• Yes, an intern pharmacist who holds a certificate confirming competency to vaccinate (including mandatory COVID-19 training) can administer specified vaccines under direct supervision of a pharmacist immuniser who holds certification to vaccinate for the relevant vaccine

• Minimum age limitations contained in vaccination standards – see above.
• Where a person cannot consent themselves (e.g. a child or an adult under the care of a parent/guardian), the
  pharmacist immuniser must ensure that the consenting person has the authority to consent for the individual.
• COVID-19 vaccine must not be administered to any individual with a contraindication or precaution to vaccine (per ATAGI, Australian Immunisation Handbook or TGA). These individuals must be referred to their medical practitioner for review. Exception: People on anti-coagulation therapy.
• Novavax vaccine can only be administered to a pregnant woman with a written request from a medical practitioner
• AstraZeneca and Novavax vaccine can only be administered to individuals aged 18 years and over as a booster dose, with a written request from a medical practitioner.

• Nil expiry

• COVID-19 AstraZeneca vaccine can only be administered after obtaining fully informed consent. Informed consent requires discussion of the risks and benefits of vaccination using the latest information and advice from ATAGI and the TGA.
• The Australian Immunisation Register must be checked prior to administering a vaccine
• Written (or other electronic evidence of) consent must be obtained for all COVID-19 vaccines
• The Australian Government Department of Health COVID-19 vaccination – Consent form for COVID-19 vaccination must be used in obtaining consent.

Additional requirements specifically apply to Pfizer’s vaccines:

• Pharmacist must store the Comirnaty (Pfizer) COVID-19 vaccine 5 to <12 years of age formulation (orange cap) separate to the Comirnaty (Pfizer) COVID-19 vaccine 12 years of age and over formulation (purple cap)
• If the two formulations are stored in the same fridge/freezer, they must be stored in separate areas, clearly labelled
• The two formulations must never be held in the same preparation or vaccination area at the same time including when drawing up
• The Comirnaty (Pfizer) COVID-19 vaccine 12 years of age and over formulation (purple cap) must never be used in the 5 to < 12 years of age cohort.
• Pharmacist must ensure the COVID-19 vaccine is administered to the deltoid muscle in children aged 5 to < 12 years, and refer to the general practitioner if there are concerns identifying the deltoid muscle

• Poisons and Therapeutic Goods Act – Section 48A

• Poisons and Therapeutic Goods Amendment (COVID-19 Vaccine) Regulation 2021 under the Poisons and Therapeutic Goods Act 1966

• NSW Pharmacist Vaccination Standards (does not apply to public health facilities, including hospitals and state-government vaccination hubs where NSW Health policy directives, authority and conditions apply)
• NSW Health COVID-19 FAQs for pharmacists

• 16 March 2021

• Per relevant COVID-19 vaccine protocols (CVAPs)

• AstraZeneca: 18 years (reason: CVAP)
• Pfizer: 12 years (reason: CVAP)
• Pfizer 5-11 years orange cap: 5 years (reason: CVAP)
• Moderna: 12 years (reason: CVAP)
• Novavax: 18 years (reasons: CVAP)

• Community pharmacy: Yes
• General Practice: Yes
• Hospitals: Yes
• ACCHOs: Yes
• Other: Yes

• No

• COVID-19 AstraZeneca Vaccination Administration Protocol
• COVID-19 COMIRNATY Vaccination Administration Protocol
• COVID-19 SPIKEVAX Vaccination Administration Protocol
• COVID-19 5-11 years ORANGE CAP Vaccine Administration Protocol
• COVID-19 Novavax Vaccination Administration Protocol

AstraZeneca CVAP does not allow first dose of AstraZeneca COVID-19 vaccines to be administered to persons under 60 years age.

Check CVAP for limitations on booster doses.

•  Nil expiry

• Section 254 Medicines, Poisons and Therapeutic Goods Act 2012 (NT)

• NT Government Gazette, Medicines, Poisons, and Therapeutic Goods ACT 2012-Declarations and approval – COVID-19 Vaccine
• COVID-19 AstraZeneca Vaccination Administration Protocol
• COVID-19 COMIRNATY Vaccination Administration Protocol
• COVID-19 SPIKEVAX Vaccination Administration Protocol
• COVID-19 5-11 years ORANGE CAP Vaccine Administration Protocol
• COVID-19 Novavax Vaccination Administration Protocol

• NT Health: Pharmacist Vaccinations
• NT Health: Immunisation for health professionals – COVID-19 vaccine

• 2 March 2022

• Any TGA registered COVID-19 vaccine

• Vaxzevria (AstraZeneca): 18 years (reason: Emergency order)
• Comirnaty (Pfizer) (purple/grey cap): 12 years (reason: Emergency order)
• Pfizer 5-11 yrs (orange cap): 5 years (reason: Emergency order)
• Spikevax (Moderna): 6 years (reason: Emergency order)
• Nuvaxovid (Novavax): 18 years (reason: Emergency order)

• Community pharmacy: Yes
• General Practice: Yes
• Hospitals: Yes
• ACCHOs: Yes
• Other: Yes

• Yes

• Limitations in the product information or as determined by the TGA approval for the vaccines apply

• At expiry of Emergency Order – Public Health Emergency
• Extended Practice Authority – Pharmacists: nil expiry

• Extended Practice Authority – Pharmacists

• Emergency Order – Public Health Emergency – Pandemic Response to Coronavirus Disease (COVID-19) Vaccination Service

• COVID-19 vaccination services policies and plans

• 2 March 2022

• Any TGA registered COVID-19 vaccine

• AstraZeneca: 18 years (reason: PI)
• Pfizer (grey/purple cap): 12 years (reason: PI)
• Pfizer 5-11 yrs (orange cap): 5 years (reason: PI)
• Moderna: 6 years (reason: PI)
• Novavax: 18 years (reason: PI)

• Community pharmacy: Yes
• General Practice: Yes
• Hospitals: Yes
• ACCHOs: Yes
• Other: Yes

• Yes

• Nil expiry

• Vaccine Administration Code (SA)

• Vaccine Administration Code (SA)

• Frequently asked questions
• Approved immunisation education programs

• 23 February 2022

• Any TGA approved COVID-19 vaccine (State Government Vaccination Clinic only)
• AstraZeneca COVID-19 vaccine and Moderna’s Spikevax (community pharmacy)

• AstraZeneca (community pharmacy): 18 years (reason: PI)
• Moderna (community pharmacy): 6 years (reason: Tasmanian Immunisation Program Guidelines)
• Pfizer (community pharmacy): 12 years (Primary Course), 18 years (booster) (reason: Tasmanian Immunisation Program Guidelines)
• Pfizer 5-11 years (ORANGE CAP) (community pharmacy): 5 years (reason: Tasmanian Immunisation Program Guidelines)
• Novavax (community pharmacy): 18 years (reason: PI)
• AstraZeneca (government hub): 18 years (reason: PI)
• Pfizer (government clinic): 12 years (reason: PI)
• Pfizer 5-11 years (ORANGE CAP) (government clinic): 5 years (reason: PI)
• Moderna (government clinic): 6 years (reason: PI)

Pharmacists in a Tasmanian community pharmacy must be specifically approved to administer vaccines to people under the age of 12 years.

• Community pharmacy: Yes, including off-site vaccination (subject to additional rules)
• General Practice: No
• Hospitals: No
• State Government vaccination clinics: Yes
• ACCHOs: No
• Other: No

• Intern Pharmacists may administer COVID-19 vaccines under the supervision of an authorised pharmacist immuniser if they hold a Statement of Attainment from the Tasmanian PSA or Pharmacy Guild and have completed their Practicum (Tasmanian Immunisation Program Guidelines).

• AstraZeneca COVID-19 vaccine can only be administered by a pharmacists in a community pharmacy to people <60 years after informed consent provided in consultation with their GP.
• Spikevax (Moderna) is approved as a booster for people >18 years.
• Comirnaty (Pfizer) can only be administered as a booster by a community pharmacist to people aged >16 years who received their second dose >3 months ago.
• People with contraindications or precautions to the COVID-19 vaccines excluded – must be referred to their GP or specialist
• Nuvaxovid (Novavax) can be used as a booster in those aged 18 years and above if no other COVID-19 vaccine is considered suitable.
• The Department of Health notes Novovax has been introduced at a stage of the roll-out when >99% of Tasmanians over the age of 18 years have received a COVID-19 vaccine. As such, the Department reminds pharmacists that it is particularly important to check the AIR and verify immunisation history with the individual prior to administering the first dose of Novavax to avoid administration errors.

• N/A

• There is a separate application process with the Tasmanian Department of Health for expansion of existing premises vaccination scope to include each COVID-19 vaccine in community pharmacies outlined in ‘Community Pharmacy Provision of COVID–19 Vaccine in Tasmania 2021 Guidelines and Application Process’.
• There is a separate application process with the Tasnmanian Department of Health for expansion of existing COVID-19 vaccinator scope to include children under the age of 12 years.

• Regulation 82 Poisons Regulations 2018

• Tasmanian Immunisation Program Guidelines Version 11 (March 2022)

• Community Pharmacy Provision of COVID19 Vaccine in Tasmania Guidelines and Application Process (PDF)

• 25 March 2022

• Any TGA registered COVID-19 vaccine

• AstraZeneca: 18 years (reason: TGA approval)
• Pfizer (grey/purple cap): 12 years (reason: TGA approval)
• Pfizer 5-11 yrs (orange cap): 5 years (reason: TGA approval)
• Moderna: 6 years (reason: TGA approval)
• Novavax: 18 years (reason: TGA approval)

• Community pharmacy: Yes
• General Practice: Yes
• Hospitals: Yes
• ACCHOs: yes, on written order of prescriber
• Other: Mobile outreach of a hospital, pharmacy or pharmacy depot; premises established my a municipal council, Victorian Government, Government of Australia or agency funded be the Department of Health (Vic)

• No

These services include where pharmacist is employed or contracted by:

• (i) a medical practitioner; or
• (ii) a municipal council that employs, contracts or ensures access to a medical practitioner or nurse practitioner; or
• (iii) a health services permit holder who employs, contracts or ensures access to a medical practitioner or nurse practitioner; or
• (iv) a health service authorised by the Victorian Government under a Public Health Emergency Order to obtain, possess, use and/or supply the COVID-19 VACCINE that employs, contracts or ensures access to a medical practitioner or nurse practitioner; or
• (v) an agency funded by the Victorian Government or the Government of Australia that employs, contracts or ensures access to a medical practitioner or nurse practitioner.

Pharmacists cannot administer COVID-19 vaccines to a person where they have contraindications described in the Approved Product Information or Australian Immunisation Handbook for that vaccine.

• May 2022

• Victorian Pharmacist-Administered Vaccination Guidelines
• Victorian COVID-19 Vaccination Guidelines
• Any current guidance issued by Victorian or Australian government
• Adverse event monitoring to occur via CVMS or SAFEVIC

• Regulation 99 Drugs, Poisons and Controlled Substances Regulations 2017

• Government Gazette 7 May 2021: Secretary Approval Pharmacist immuniser – SARS-CoV-2 (COVID-19) vaccine

• Information for vaccine providers (Department of Health, Victoria)

• 23 February 2022

• TGA registered COVID-19 vaccines

• AstraZeneca: 18 years (reason: National roll-out plan per SASA)
• Pfizer (purple cap): 12 years (reason: National roll-out plan per SASA)
• Pfizer 5-11 yrs (orange cap): 5 years (reason: National roll-out plan per SASA)
• Moderna: 6 years (reason: National roll-out plan per SASA)
• Novavax: 18 years (reason: National roll-out plan per SASA)

• Community pharmacy: Yes
• General Practice: Yes, on written order of medical prescriber
• Public hospitals: Yes
• Vaccination Hubs: Yes
• ACCHOs: No

• Yes

• Nil expiry: SASA- Pharmacists (COVID-19)
• Pharmacists (WA Health) – COVID-19 vaccination

• Adverse events following immunisation must be notified to WAVSS

• SASA- Pharmacists (COVID-19)
• Pharmacists (WA Health) – COVID-19 vaccination

•  23 February 2022